Clinical Trial Update: Early Immunotherapy with Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients with Anti-Hu-associated Paraneoplastic Sensory Neuronopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early immunotherapy with intravenous immunoglobulin, cyclophosphamide, and methylprednisolone in patients with anti-Hu-associated paran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraneoplastic Sensory Neuronopathy

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Intravenous Immunoglobulin (IVIG)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Paraneoplastic Sensory Neuronopathy | Phase 2 | Status: RECRUITING